News

  • Quotient Sciences Acquires Pharmaterials

    Quotient Sciences (“Quotient”), the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K. The acquisition strengthens and expands Quotient’s formulation and manufacturing services footprint in the U.K., and further supports the growth of Quotient’s Translational Pharmaceutics® platform, following the acquisitions of SeaView Research and […]

    Read More..
  • Pharmaterials appoints new Director of Material Science

    Pharmaterials is please to announce the appointment of Dr Jason Gray as Director of Material Science. Jason brings a wealth of knowledge, having over 20 years’ experience within the pharmaceutical and related industries working from discovery through solid form design and optimisation, formulation development to regulatory approval. During this time has headed up several research […]

    Read More..
  • Investment in New Raman Microscope

    Due to the importance of Raman mapping and analysis for understanding physical profiles (form, particle size, etc.) and formulation issues, Pharmaterials are pleased to announce the investment in an upgraded state of the art confocal Raman Microscope. The new system will replace the existing capability and will enable Pharmaterials to provide an enhanced service and […]

    Read More..
  • New GMP Hot Melt Extrusion

    With over a decade of experience in the formulation, characterisation and manufacture of stabilised amorphous dispersions, Pharmaterials are pleased to extend their capabilities in the field with the addition of a cGMP Leistritz Hot Melt Extruder. Hot Melt Extrusion (HME) is a proven processing technology for the development of pharmaceutical products with improved performance and […]

    Read More..
  • Update on Facility Expansion

    Pharmaterials are pleased to announce the completion of building work to expand its manufacturing base and laboratories in Reading. The expansion will increase its manufacturing capacity by 300% and will allow the creation of a new analytical and inhalation lab as well as expansion of other lab services. Over the coming months the labs will […]

    Read More..
  • Meet us at PharmSci 2014

    Pharmaterials will be exhibiting at ‘Pharm Sci’ 2014. 10th September, University of Hertfordshire, Hatfield.

    Read More..
  • Manufacturing and Stability Expansion

    Pharmaterials are pleased to announce the expansion of their manufacturing, analytical and stability facilities. Due to the continued growth of the business and to meet our customers’ needs in the future, Pharmaterials is investing significantly to expand the GMP manufacturing operations at their Reading, UK site.The addition of new GMP manufacturing rooms to the existing […]

    Read More..
  • Meet us at Biomed, Israel 2014

    Pharmaterials will be exhibiting at Biomed, 20th-22nd May 2014. Meet us to discuss your Manufacturing, Development and Formulation needs. Biomed 2014, 20th-22nd May, Tel Aviv, Israel.

    Read More..
  • Appointment of Nicola Dixon

    Nicola, who joins Pharmaterials as Director.

    Read More..
  • Meet us at Biomed, Israel 2014

    Pharmaterials will be exhibiting at Biomed, 20th-22nd May 2014. Meet us to discuss your Manufacturing, Development and Formulation needs. Biomed 2014, 20th-22nd May, Tel Aviv, Israel.

    Read More..